Metallotherapeutic drugs and metal-based diagnostic agents : the use of metals in medicine / [edited by] Marcel Gielen, Edward R. T. Tiekink |
Pubbl/distr/stampa | Chichester [etc.], : Wiley, c2005 |
Descrizione fisica | XXXIX, 598 p. : ill. ; 24 cm. |
Disciplina | 615.23(Chimica farmaceutica. Metalli) |
ISBN | 04-7086-403-6 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNICAMPANIA-SUN0071233 |
Chichester [etc.], : Wiley, c2005 | ||
![]() | ||
Lo trovi qui: Univ. Vanvitelli | ||
|
Metallotherapeutic drugs and metal-based diagnostic agents [[electronic resource] ] : the use of metals in medicine / / [edited by] Marcel Gielen, Edward R.T. Tiekink |
Pubbl/distr/stampa | Hoboken, N.J., : Wiley, c2005 |
Descrizione fisica | 1 online resource (644 p.) |
Disciplina |
615.23
615/.23 |
Altri autori (Persone) |
GielenM <1938-> (Marcel)
TiekinkEdward R. T |
Soggetto topico |
Metals - Therapeutic use
Metals - Diagnostic use |
Soggetto genere / forma | Electronic books. |
ISBN |
1-280-23877-1
9786610238774 0-470-29820-0 0-470-86404-4 0-470-86405-2 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
METALLOTHERAPEUTIC DRUGS AND METAL-BASED DIAGNOSTIC AGENTS; Contents; List of Contributors; Preface; 1 (3)Li Lithium Metallotherapeutics; 1.1 Introduction; 1.2 The Inorganic Chemistry of Lithium; 1.3 Biology of Lithium; 1.3.1 The history of lithium therapeutics; 1.3.2 Lithium and the body; 1.4 Targets of Lithium; 1.4.1 Glycogen synthase kinase-3; 1.4.2 Inositol phosphate signalling; 1.5 Lithium Therapeutics; 1.5.1 Bipolar disorder and schizophrenia; 1.5.2 Alzheimer's disease; 1.5.3 Ischemia (stroke); 1.5.4 Adverse effects; Acknowledgements; References
2 (5)B Boron Compounds as Therapeutic Drugs2.1 Boron Neutron Capture Therapy; 2.2 Classes of Boron Compounds for Potential Use in BNCT; 2.2.1 DNA binders; 2.2.2 Boron-containing amino acids and related peptides; 2.2.3 Boron-containing nucleic acid precursors; 2.3 Phosphates, Phosphonates and Phosphoramidates; 2.4 Amines; 2.5 Boron Analogues of Pyrophosphates; 2.6 Boronated Polyamines; 2.7 Carbohydrates; 2.8 Lipoproteins; 2.9 Lipids and Phospholipids; 2.10 Radiation Sensitizers; 2.11 Cyclic Thiourea Derivatives 2.12 Central Nervous System (CNS) Depressants: Promazines, Hydantoins and Barbiturates2.13 Hydantoins and Barbiturates; 2.14 Oligonucleotide Antisense Agents; 2.15 Hormones; 2.16 Liposomes; 2.17 Conclusions; Acknowledgements; References; 3 (12)Mg The Role of Magnesium as a Metallotherapeutic Drug; 3.1 Introduction; 3.2 Magnesium as a Drug; 3.2.1 Gestational hypertension, preeclampsia and eclampsia; 3.2.2 Asthma; 3.2.3 Stroke; 3.2.4 Acute myocardial infarction; 3.2.5 Arrhythmias; 3.2.6 Miscellaneous; References; 4 (13)Al Aluminum Metallotherapeutics; 4.1 Introduction; 4.2 Adjuvants; 4.2.1 Alum 4.2.2 Al(OH)(3)4.2.3 Aluminum phosphate; 4.3 Antacids; 4.3.1 Aluminum hydroxide; 4.3.2 Aluminum glycinate; 4.3.3 Peptic ulcer disease; 4.3.4 Bismuth aluminum carbonate; 4.3.5 Bismuth-magnesium-sodium alumino-silicate; 4.4 Phosphate Binders; 4.4.1 Basic aluminum carbonate; 4.4.2 Alumino-silicates; 4.5 Alginate Raft Formulations; 4.6 Blistering Diseases in the Elderly; 4.7 Metabolic Diseases and Aluminum; 4.8 Anti-malarial Substances; 4.9 Potential Aluminum Toxicity; 4.10 Conclusions; References; 5 (14)Si Biological Activity of Organosilicon Compounds; 5.1 Introduction 5.2 Organosilicon Modification5.2.1 O-, S- and N-Silylation; 5.2.2 C-Silylation; 5.3 Sila Analogues; 5.4 Specific Organosilicon Compounds; References; 6 (20)Ca The Role of Calcium as a Metallotherapeutic Drug; 6.1 Introduction; 6.2 Calcium Homeostasis; 6.3 Hormonal Regulation of Calcium Metabolism; 6.4 Optimal Amount of Dietary Calcium Intake and Benefits of Calcium Supplementation; 6.5 Osteoporosis; 6.6 Hypertension; 6.7 Hypertension in Pregnancy and Preeclampsia; 6.8 Colon Cancer; 6.9 Weight Control and Regulation of Body Fat; 6.10 Periodontal Disease; 6.11 Kidney Stones 6.12 Calcium Supplements: Side Effects |
Record Nr. | UNINA-9910147221003321 |
Hoboken, N.J., : Wiley, c2005 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Metallotherapeutic drugs and metal-based diagnostic agents : the use of metals in medicine / [edited by] Marcel Gielen, Edward R. T. Tiekink |
Pubbl/distr/stampa | Chichester [etc.], : Wiley, c2005 |
Descrizione fisica | XXXIX, 598 p. : ill. ; 24 cm |
Disciplina | 615.23(Chimica farmaceutica. Metalli) |
ISBN | 04-7086-403-6 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNICAMPANIA-VAN0071233 |
Chichester [etc.], : Wiley, c2005 | ||
![]() | ||
Lo trovi qui: Univ. Vanvitelli | ||
|
Metallotherapeutic drugs and metal-based diagnostic agents [[electronic resource] ] : the use of metals in medicine / / [edited by] Marcel Gielen, Edward R.T. Tiekink |
Pubbl/distr/stampa | Hoboken, N.J., : Wiley, c2005 |
Descrizione fisica | 1 online resource (644 p.) |
Disciplina |
615.23
615/.23 |
Altri autori (Persone) |
GielenM <1938-> (Marcel)
TiekinkEdward R. T |
Soggetto topico |
Metals - Therapeutic use
Metals - Diagnostic use |
ISBN |
1-280-23877-1
9786610238774 0-470-29820-0 0-470-86404-4 0-470-86405-2 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
METALLOTHERAPEUTIC DRUGS AND METAL-BASED DIAGNOSTIC AGENTS; Contents; List of Contributors; Preface; 1 (3)Li Lithium Metallotherapeutics; 1.1 Introduction; 1.2 The Inorganic Chemistry of Lithium; 1.3 Biology of Lithium; 1.3.1 The history of lithium therapeutics; 1.3.2 Lithium and the body; 1.4 Targets of Lithium; 1.4.1 Glycogen synthase kinase-3; 1.4.2 Inositol phosphate signalling; 1.5 Lithium Therapeutics; 1.5.1 Bipolar disorder and schizophrenia; 1.5.2 Alzheimer's disease; 1.5.3 Ischemia (stroke); 1.5.4 Adverse effects; Acknowledgements; References
2 (5)B Boron Compounds as Therapeutic Drugs2.1 Boron Neutron Capture Therapy; 2.2 Classes of Boron Compounds for Potential Use in BNCT; 2.2.1 DNA binders; 2.2.2 Boron-containing amino acids and related peptides; 2.2.3 Boron-containing nucleic acid precursors; 2.3 Phosphates, Phosphonates and Phosphoramidates; 2.4 Amines; 2.5 Boron Analogues of Pyrophosphates; 2.6 Boronated Polyamines; 2.7 Carbohydrates; 2.8 Lipoproteins; 2.9 Lipids and Phospholipids; 2.10 Radiation Sensitizers; 2.11 Cyclic Thiourea Derivatives 2.12 Central Nervous System (CNS) Depressants: Promazines, Hydantoins and Barbiturates2.13 Hydantoins and Barbiturates; 2.14 Oligonucleotide Antisense Agents; 2.15 Hormones; 2.16 Liposomes; 2.17 Conclusions; Acknowledgements; References; 3 (12)Mg The Role of Magnesium as a Metallotherapeutic Drug; 3.1 Introduction; 3.2 Magnesium as a Drug; 3.2.1 Gestational hypertension, preeclampsia and eclampsia; 3.2.2 Asthma; 3.2.3 Stroke; 3.2.4 Acute myocardial infarction; 3.2.5 Arrhythmias; 3.2.6 Miscellaneous; References; 4 (13)Al Aluminum Metallotherapeutics; 4.1 Introduction; 4.2 Adjuvants; 4.2.1 Alum 4.2.2 Al(OH)(3)4.2.3 Aluminum phosphate; 4.3 Antacids; 4.3.1 Aluminum hydroxide; 4.3.2 Aluminum glycinate; 4.3.3 Peptic ulcer disease; 4.3.4 Bismuth aluminum carbonate; 4.3.5 Bismuth-magnesium-sodium alumino-silicate; 4.4 Phosphate Binders; 4.4.1 Basic aluminum carbonate; 4.4.2 Alumino-silicates; 4.5 Alginate Raft Formulations; 4.6 Blistering Diseases in the Elderly; 4.7 Metabolic Diseases and Aluminum; 4.8 Anti-malarial Substances; 4.9 Potential Aluminum Toxicity; 4.10 Conclusions; References; 5 (14)Si Biological Activity of Organosilicon Compounds; 5.1 Introduction 5.2 Organosilicon Modification5.2.1 O-, S- and N-Silylation; 5.2.2 C-Silylation; 5.3 Sila Analogues; 5.4 Specific Organosilicon Compounds; References; 6 (20)Ca The Role of Calcium as a Metallotherapeutic Drug; 6.1 Introduction; 6.2 Calcium Homeostasis; 6.3 Hormonal Regulation of Calcium Metabolism; 6.4 Optimal Amount of Dietary Calcium Intake and Benefits of Calcium Supplementation; 6.5 Osteoporosis; 6.6 Hypertension; 6.7 Hypertension in Pregnancy and Preeclampsia; 6.8 Colon Cancer; 6.9 Weight Control and Regulation of Body Fat; 6.10 Periodontal Disease; 6.11 Kidney Stones 6.12 Calcium Supplements: Side Effects |
Record Nr. | UNINA-9910830892403321 |
Hoboken, N.J., : Wiley, c2005 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Metallotherapeutic drugs and metal-based diagnostic agents : the use of metals in medicine / [edited by] Marcel Gielen, Edward R. T. Tiekink |
Pubbl/distr/stampa | Chichester [etc.], : Wiley, c2005 |
Descrizione fisica | XXXIX, 598 p. : ill. ; 24 cm |
Disciplina | 615.23(Chimica farmaceutica. Metalli) |
ISBN | 04-7086-403-6 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNICAMPANIA-VAN00071233 |
Chichester [etc.], : Wiley, c2005 | ||
![]() | ||
Lo trovi qui: Univ. Vanvitelli | ||
|
Uses of inorganic chemistry in medicine [[electronic resource] /] / edited by Nicholas P. Farrell |
Pubbl/distr/stampa | Cambridge, : Royal Society of Chemistry, 1999 |
Descrizione fisica | 1 online resource (174 p.) |
Disciplina |
546
615.23 |
Altri autori (Persone) | FarrellNicholas P |
Soggetto topico | Chemistry, Inorganic |
Soggetto genere / forma | Electronic books. |
ISBN |
1-62870-135-8
1-84755-224-2 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | BK9780854044443-FX001; BK9780854044443-FP001; BK9780854044443-FP005; BK9780854044443-FP007; BK9780854044443-00001; BK9780854044443-00011; BK9780854044443-00026; BK9780854044443-00058; BK9780854044443-00077; BK9780854044443-00093; BK9780854044443-00109; BK9780854044443-00124; BK9780854044443-00135; BK9780854044443-00158 |
Record Nr. | UNINA-9910455234003321 |
Cambridge, : Royal Society of Chemistry, 1999 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Uses of inorganic chemistry in medicine [[electronic resource] /] / edited by Nicholas P. Farrell |
Pubbl/distr/stampa | Cambridge, : Royal Society of Chemistry, 1999 |
Descrizione fisica | 1 online resource (174 p.) |
Disciplina |
546
615.23 |
Altri autori (Persone) | FarrellNicholas P |
Soggetto topico | Chemistry, Inorganic |
ISBN |
1-62870-135-8
1-84755-224-2 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | BK9780854044443-FX001; BK9780854044443-FP001; BK9780854044443-FP005; BK9780854044443-FP007; BK9780854044443-00001; BK9780854044443-00011; BK9780854044443-00026; BK9780854044443-00058; BK9780854044443-00077; BK9780854044443-00093; BK9780854044443-00109; BK9780854044443-00124; BK9780854044443-00135; BK9780854044443-00158 |
Record Nr. | UNINA-9910778306703321 |
Cambridge, : Royal Society of Chemistry, 1999 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Uses of inorganic chemistry in medicine / / edited by Nicholas P. Farrell |
Edizione | [1st ed.] |
Pubbl/distr/stampa | Cambridge, : Royal Society of Chemistry, 1999 |
Descrizione fisica | 1 online resource (174 p.) |
Disciplina |
546
615.23 |
Altri autori (Persone) | FarrellNicholas P |
Soggetto topico | Chemistry, Inorganic |
ISBN |
1-62870-135-8
1-84755-224-2 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | BK9780854044443-FX001; BK9780854044443-FP001; BK9780854044443-FP005; BK9780854044443-FP007; BK9780854044443-00001; BK9780854044443-00011; BK9780854044443-00026; BK9780854044443-00058; BK9780854044443-00077; BK9780854044443-00093; BK9780854044443-00109; BK9780854044443-00124; BK9780854044443-00135; BK9780854044443-00158 |
Record Nr. | UNINA-9910810881003321 |
Cambridge, : Royal Society of Chemistry, 1999 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|